Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis

Background. Atrial fibrillation (AF) is the most common serious cardiac rhythm disturbances and is responsible for substantial morbidity and mortality in general population. Hypertension is the most prevalent and potentially modifiable risk factor for AF. This study is aimed at evaluating the effect...

書誌詳細
主要な著者:	Haotian Ma, Hongcheng Jiang, Jing Feng, Yong Gan
フォーマット:	論文
言語:	English
出版事項:	Hindawi-Wiley 2021-01-01
シリーズ:	Cardiovascular Therapeutics
オンライン･アクセス:	http://dx.doi.org/10.1155/2021/6628469

類似資料

Angiotensin&nbsp;II receptor blockers in the prevention of complications from atrial fibrillation
著者:: Gerald V Naccarelli, 等
出版事項: (2009-09-01)

Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention
著者:: Cesare Cuspidi, 等
出版事項: (2008-02-01)

A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
著者:: Ji-Guang Wang
出版事項: (2009-07-01)

Long-term observation of fibrillation cycle length in patients under angiotensin II receptor blocker therapy for chronic atrial fibrillation
著者:: Jun Kishihara, 等
出版事項: (2012-02-01)

Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension
著者:: E. V. Kokhan, 等
出版事項: (2021-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
著者:: O. M. Drapkina, 等
出版事項: (2014-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
著者:: O. M. Drapkina, 等
出版事項: (2014-07-01)

Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery
著者:: Weiss Michael J, 等
出版事項: (2010-02-01)

Angiotensin‐Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New‐Onset Atrial Fibrillation After Acute Myocardial Infarction
著者:: Gorav Batra, 等
出版事項: (2017-03-01)

Termination of Aconitine-Induced Atrial Fibrillation by the KACh-Channel Blocker Tertiapin: Underlying Electrophysiological Mechanism
著者:: Kazumasa Suzuki, 等
出版事項: (2014-01-01)

Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation
著者:: Nicole Habel, 等
出版事項: (2023-06-01)

Effect of β-blockers on the risk of atrial fibrillation in patients with acute myocardial infarction
著者:: Antonio Eduardo Pesaro, 等
出版事項: (2010-01-01)

Calcium channel blockers, more than diuretics, enhance vascular protective effects of angiotensin receptor blockers in salt-loaded hypertensive rats.
著者:: Eiichiro Yamamoto, 等
出版事項: (2012-01-01)

Organization of atrial fibrillation using a pure sodium channel blocker: Implications of rotor ablation therapy
著者:: Tadafumi Nanbu, 等
出版事項: (2023-06-01)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
著者:: Hyun Woong Lee
出版事項: (2014-12-01)

Correction: Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
出版事項: (2013-01-01)

Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes
著者:: Nishida Yayoi, 等
出版事項: (2012-05-01)

The haemodynamic changes associated with treatment of new-onset atrial fibrillation with amiodarone or beta blockers
著者:: Bedford, J, 等
出版事項: (2021)

Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation
著者:: Yanhua Yang, 等
出版事項: (2020-01-01)

Acute Management of Paroxysmal Atrial Fibrillation with Intravenous Flecainide plus Oral Beta-Blockers
著者:: Athanasios Kartalis, 等
出版事項: (2024-06-01)

Which beta-blocker should be used for the prevention of postoperative atrial fibrillation in cardiac surgery? A multi-treat
著者:: Mohamed Zeinah, 等
出版事項: (2016-06-01)

Novel beta-blocker pretreatment prevents alcohol-induced atrial fibrillation in a rat modelKey Findings
著者:: Hebah Hassan, BS, 等
出版事項: (2020-06-01)

The use of angiotensin receptor blockers in dementia prevention
著者:: Jordana de Araujo Müller, 等
出版事項: (2023-09-01)

Effect of angiotensin receptor-neprilysin inhibitor on atrial electrical instability in atrial fibrillation
著者:: Tianyu Zhu, 等
出版事項: (2022-12-01)

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: An individual-patient data meta-analysis
著者:: Kotecha, D, 等
出版事項: (2014)

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
著者:: Kotecha, D, 等
出版事項: (2014)

Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction
著者:: Akif Arslan, 等
出版事項: (2016-01-01)

Effects of Angiotensin Receptor Blockers on Apelin and Visfatin in Hypertension
著者:: Mina Mohammed, 等
出版事項: (2024-06-01)

Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
著者:: Yen-Chung Lin, 等
出版事項: (2017-01-01)

COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT)
著者:: O. V. Dralova, 等
出版事項: (2016-01-01)

Effect of angiotensin II receptor blockers and calcium antagonists on cognition
著者:: O. D. Ostroumova, 等
出版事項: (2016-12-01)

β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis
著者:: Tianyu Xu, 等
出版事項: (2019-06-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
著者:: M. A. Maksimova, 等
出版事項: (2015-09-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
著者:: M. A. Maksimova, 等
出版事項: (2015-09-01)

Real-world efficacy of fimasartan vs. other angiotensin receptor blockers in combination with calcium channel blockers: a nationwide cohort study
著者:: Huijin Lee, 等
出版事項: (2024-10-01)

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
著者:: Volpe M, 等
出版事項: (2012-06-01)

Differential Effects in Cardiovascular Markers between High-Dose Angiotensin II Receptor Blocker Monotherapy and Combination Therapy of ARB with Calcium Channel Blocker in Hypertension (DEAR Trial)
著者:: Kenichiro Kinouchi, 等
出版事項: (2011-01-01)

Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up
著者:: Han Saem Jeong, 等
出版事項: (2021-01-01)

Lowering serum homocysteine in H-type hypertensive patients with atrial fibrillation after radiofrequency catheter ablation to prevent atrial fibrillation recurrence
著者:: Youzheng Dong, 等
出版事項: (2022-09-01)

Managing postoperative atrial fibrillation after open-heart surgery using transdermal β1 blockers
著者:: Kenji Yamamoto, 等
出版事項: (2023-04-01)